Abstract
Escape variants can cause new waves of COVID-19 outbreaks and put vaccination strategies at risk. To prevent or delay the global spread of these waves, virus mobility needs to be minimised through screening and testing strategies, which should also cover vaccinated people. The costs of these strategies are minimal compared to the costs to health, society and the economy from another wave.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andreano, E., G. Piccini, D. Licastro, L. Casalino, N. V. Johnson, I. Paciello, S. Dal Monego, E. Pantano, N. Manganaro, A. Manenti, R. Manna, E. Casa, I. Hyseni, L. Benincasa, E. Montomoli, R. E. Amaro, J. S. McLellan and R. Rappuoli (2020), SARSCoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma, bioRxiv, 2020.12.28.424451.
Castillo, J. C., A. Ahuja, S. Athey, A. Baker, E. Budish, T. Chipty, R. Glennerster, S. D. Kominers, M. Kremer, G. Larson, J. Lee, C. Prendergast, C. M Snyder, A. Tabarrok, B. J. Tan and W. Wiecek (2021), Market design to accelerate COVID-19 vaccine supply, Science, 371(6534), 1107–1109.
Contreras, S., J. Dehning, M. Loidolt, J. Zierenberg, F. P. Spitzner, J. H. Urrea-Quintero, S. B. Mohr, M. Wilczek, M. Wibral and V. Priesemann (2021), The challenges of containing SARS-CoV-2 via test-trace-and-isolate, Nature Communications, 12, 378.
Cutler, D. M. and L. H. Summers (2020), The COVID-19 Pandemic and the $16 Trillion Virus, JAMA, 324(15), 1495–1496.
Cyranoski, D. (2021), Alarming COVID variants show vital role of genomic surveillance, Nature, 589, 337–338.
Dagan, N., N. Barda, E. Kepten, O. Miron, S. Perchik, M. A. Katz, M. A. Hernán, M. Lipsitch, B. Reis and R. D. Balicer (2021), BNT162b2 mR-NA, Covid-19 Vaccine in a Nationwide Mass Vaccination Setting, New England Journal of Medicine, 384, 1412–1423.
McCormick, K. D., J. L. Jacobs and J. W. Mellors (2021), The emerging plasticity of SARS-CoV-2, Science, 371(6536), 1306–1308.
Oliu-Barton, M., B. Pradelski, P. Aghion, P. Artus, I. Kickbusch, J. V. Lazarus, D. Sridhar and S. Vanderslott (2021), SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties, Lancet, 397(10291), 2234–2236.
Phillips, N. (2021), The coronavirus is here to stay — here’s what that means, Nature, 590, 382–384.
Priesemann, V., M. M. Brinkmann, S. Ciesek, S. Cuschieri, T. Czypionka, G. Giordano, D. Gurdasani, C. Hanson, N. Hens, E. Iftekhar, M. Kelly-Irving, P. Klimek, M. Kretzschmar, A. Peichl, M. Perc, F. Sannino, E. Schernhammer, A. Schmidt, A. Staines and E. Szczurek (2021), Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections, Lancet, 397(10269), 92–93.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Martin Hellwig, Max Planck Institute for Research on Collective Goods, Bonn, Germany.
Viola Priesemann, Max Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Guntram B. Wolff, Bruegel, Brussels, Belgium.
Rights and permissions
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Open Access funding provided by ZBW — Leibniz Information Centre for Economics.
About this article
Cite this article
Hellwig, M., Priesemann, V. & Wolff, G.B. Reducing the Mobility of SARS-CoV-2 Variants to Safeguard Containments. Intereconomics 56, 234–236 (2021). https://doi.org/10.1007/s10272-021-0987-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10272-021-0987-4